BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

495 related articles for article (PubMed ID: 19059538)

  • 1. Berberine reduces insulin resistance through protein kinase C-dependent up-regulation of insulin receptor expression.
    Kong WJ; Zhang H; Song DQ; Xue R; Zhao W; Wei J; Wang YM; Shan N; Zhou ZX; Yang P; You XF; Li ZR; Si SY; Zhao LX; Pan HN; Jiang JD
    Metabolism; 2009 Jan; 58(1):109-19. PubMed ID: 19059538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Berberine lowers blood glucose in type 2 diabetes mellitus patients through increasing insulin receptor expression.
    Zhang H; Wei J; Xue R; Wu JD; Zhao W; Wang ZZ; Wang SK; Zhou ZX; Song DQ; Wang YM; Pan HN; Kong WJ; Jiang JD
    Metabolism; 2010 Feb; 59(2):285-92. PubMed ID: 19800084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein kinase D activation stimulates the transcription of the insulin receptor gene.
    Zhang H; Kong WJ; Shan YQ; Song DQ; Li Y; Wang YM; You XF; Jiang JD
    Mol Cell Endocrinol; 2010 Dec; 330(1-2):25-32. PubMed ID: 20674666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Berberine improves insulin resistance in cardiomyocytes via activation of 5'-adenosine monophosphate-activated protein kinase.
    Chang W; Zhang M; Li J; Meng Z; Wei S; Du H; Chen L; Hatch GM
    Metabolism; 2013 Aug; 62(8):1159-67. PubMed ID: 23537779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A preliminary investigation of the mechanisms underlying the effect of berberine in preventing high-fat diet-induced insulin resistance in rats.
    Gu JJ; Gao FY; Zhao TY
    J Physiol Pharmacol; 2012 Oct; 63(5):505-13. PubMed ID: 23211304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Berberine analogue IMB-Y53 improves glucose-lowering efficacy by averting cellular efflux especially P-glycoprotein efflux.
    Shan YQ; Ren G; Wang YX; Pang J; Zhao ZY; Yao J; You XF; Si SY; Song DQ; Kong WJ; Jiang JD
    Metabolism; 2013 Mar; 62(3):446-56. PubMed ID: 23079743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Berberine treatment attenuates the palmitate-mediated inhibition of glucose uptake and consumption through increased 1,2,3-triacyl-sn-glycerol synthesis and accumulation in H9c2 cardiomyocytes.
    Chang W; Chen L; Hatch GM
    Biochim Biophys Acta; 2016 Apr; 1861(4):352-62. PubMed ID: 26774040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoglycemic and insulin-sensitizing effects of berberine in high-fat diet- and streptozotocin-induced diabetic rats.
    Wang Y; Campbell T; Perry B; Beaurepaire C; Qin L
    Metabolism; 2011 Feb; 60(2):298-305. PubMed ID: 20304443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Berberine and its more biologically available derivative, dihydroberberine, inhibit mitochondrial respiratory complex I: a mechanism for the action of berberine to activate AMP-activated protein kinase and improve insulin action.
    Turner N; Li JY; Gosby A; To SW; Cheng Z; Miyoshi H; Taketo MM; Cooney GJ; Kraegen EW; James DE; Hu LH; Li J; Ye JM
    Diabetes; 2008 May; 57(5):1414-8. PubMed ID: 18285556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Berberine reducing insulin resistance by up-regulating IRS-2 mRNA expression in nonalcoholic fatty liver disease (NAFLD) rat liver.
    Xing LJ; Zhang L; Liu T; Hua YQ; Zheng PY; Ji G
    Eur J Pharmacol; 2011 Oct; 668(3):467-71. PubMed ID: 21839075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Berberine improves glucose metabolism in diabetic rats by inhibition of hepatic gluconeogenesis.
    Xia X; Yan J; Shen Y; Tang K; Yin J; Zhang Y; Yang D; Liang H; Ye J; Weng J
    PLoS One; 2011 Feb; 6(2):e16556. PubMed ID: 21304897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Berberine improves free-fatty-acid-induced insulin resistance in L6 myotubes through inhibiting peroxisome proliferator-activated receptor gamma and fatty acid transferase expressions.
    Chen Y; Li Y; Wang Y; Wen Y; Sun C
    Metabolism; 2009 Dec; 58(12):1694-702. PubMed ID: 19767038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Berberine protects mice against type 2 diabetes by promoting PPARĪ³-FGF21-GLUT2-regulated insulin sensitivity and glucose/lipid homeostasis.
    Chen Y; Li Q; Zhao S; Sun L; Yin Z; Wang X; Li X; Iwakiri Y; Han J; Duan Y
    Biochem Pharmacol; 2023 Dec; 218():115928. PubMed ID: 37979703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and biological evaluation of berberine analogues as novel up-regulators for both low-density-lipoprotein receptor and insulin receptor.
    Wang YX; Wang YP; Zhang H; Kong WJ; Li YH; Liu F; Gao RM; Liu T; Jiang JD; Song DQ
    Bioorg Med Chem Lett; 2009 Nov; 19(21):6004-8. PubMed ID: 19800225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Berberine, a natural antidiabetes drug, attenuates glucose neurotoxicity and promotes Nrf2-related neurite outgrowth.
    Hsu YY; Tseng YT; Lo YC
    Toxicol Appl Pharmacol; 2013 Nov; 272(3):787-96. PubMed ID: 23954465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In silico network pharmacology and in vivo analysis of berberine-related mechanisms against type 2 diabetes mellitus and its complications.
    Di S; Han L; An X; Kong R; Gao Z; Yang Y; Wang X; Zhang P; Ding Q; Wu H; Wang H; Zhao L; Tong X
    J Ethnopharmacol; 2021 Aug; 276():114180. PubMed ID: 33957209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Berberine alleviates hyperglycemia by targeting hepatic glucokinase in diabetic db/db mice.
    Li M; Dang Y; Li Q; Zhou W; Zuo J; Yao Z; Zhang L; Ji G
    Sci Rep; 2019 May; 9(1):8003. PubMed ID: 31142783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Berberine-induced activation of 5'-adenosine monophosphate-activated protein kinase and glucose transport in rat skeletal muscles.
    Ma X; Egawa T; Kimura H; Karaike K; Masuda S; Iwanaka N; Hayashi T
    Metabolism; 2010 Nov; 59(11):1619-27. PubMed ID: 20423742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Berberine up-regulates hepatic low-density lipoprotein receptor through Ras-independent but AMP-activated protein kinase-dependent Raf-1 activation.
    Li Z; Jiang JD; Kong WJ
    Biol Pharm Bull; 2014; 37(11):1766-75. PubMed ID: 25196457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of maternal diabetes on expression of insulin-like growth factor-1 and insulin receptors in male developing rat hippocampus.
    Hami J; Sadr-Nabavi A; Sankian M; Balali-Mood M; Haghir H
    Brain Struct Funct; 2013 Jan; 218(1):73-84. PubMed ID: 22241286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.